-
EP2440177
European procedure
Extract from the Register of European Patents
EP About this file: EP2440177
| EP2440177 - PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.07.2016 Database last updated on 26.04.2025 | Most recent event Tooltip | 19.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 21.11.2018 [2018/47] | Applicant(s) | For all designated states Abbott GmbH & Co. KG Max-Planck-Ring 2 65205 Wiesbaden / DE | [2012/16] | Inventor(s) | 01 /
PACKHAEUSER, Claudia Burgstrasse 7 68165 Mannheim / DE | 02 /
STEIGER, Norbert Druslacherstrasse 1 67360 Lingenfeld / DE | 03 /
LIEPOLD, Bernd Birkenweg 44 69221 Dossenheim / DE | 04 /
KOSTELAC, Drazen R4 15 68161 Mannheim / DE | 05 /
KNOBLOCH, Martin Medenheimer Strasse 22a 67141 Neuhofen / DE | [2012/16] | Representative(s) | Modiano, Micaela Nadia, et al Modiano & Partners (DE) Thierschstrasse 11 80538 München / DE | [2012/16] | Application number, filing date | 10742875.7 | 08.06.2010 | [2015/38] | WO2010IB01659 | Priority number, date | US20090185130P | 08.06.2009 Original published format: US 185130 P | [2012/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2010143074 | Date: | 16.12.2010 | Language: | EN | [2010/50] | Type: | A2 Application without search report | No.: | EP2440177 | Date: | 18.04.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.12.2010 takes the place of the publication of the European patent application. | [2012/16] | Type: | B1 Patent specification | No.: | EP2440177 | Date: | 16.09.2015 | Language: | EN | [2015/38] | Search report(s) | International search report - published on: | EP | 17.02.2011 | Supplementary international search report - requested on: | RU | 05.01.2011 | Classification | IPC: | A61K9/00, A61K31/5377, A61K9/14 | [2012/16] | CPC: |
A61K31/635 (EP,CN,KR,US);
A61K9/00 (RU);
A61K9/146 (EP,CN,KR,US);
A61K9/0053 (EP,CN,KR,US);
A61K31/5377 (KR,RU);
A61K9/14 (RU);
A61K9/20 (KR);
A61K9/2013 (US);
A61K9/2027 (US);
A61K9/2095 (US);
A61K9/4833 (KR,US);
A61P35/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/16] | Extension states | BA | 29.12.2011 | ME | 29.12.2011 | RS | 29.12.2011 | Title | German: | PHARMAZEUTISCHE DOSIERUNGSFORM ZUR ORALEN VERABREICHUNG EINES HEMMERS DER BCL-2-FAMILIE | [2012/16] | English: | PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR | [2012/16] | French: | FORME POSOLOGIQUE PHARMACEUTIQUE POUR L'ADMINISTRATION ORALE D'UN INHIBITEUR DE LA FAMILLE DE BCL-2 | [2012/16] | Entry into regional phase | 29.12.2011 | National basic fee paid | 29.12.2011 | Designation fee(s) paid | 29.12.2011 | Examination fee paid | Examination procedure | 29.12.2011 | Examination requested [2012/16] | 16.07.2012 | Amendment by applicant (claims and/or description) | 02.04.2015 | Communication of intention to grant the patent | 05.08.2015 | Fee for grant paid | 05.08.2015 | Fee for publishing/printing paid | 05.08.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | EP15184904.9 / EP2982366 | EP17181461.9 / EP3272334 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.04.2015 | Opposition(s) | 17.06.2016 | No opposition filed within time limit [2016/34] | Fees paid | Renewal fee | 31.03.2012 | Renewal fee patent year 03 | 31.03.2013 | Renewal fee patent year 04 | 31.03.2014 | Renewal fee patent year 05 | 05.06.2015 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 16.09.2015 | MK | 16.09.2015 | [2018/47] |
| Former [2018/30] | MK | 16.09.2015 | Cited in | International search | [Y]RU2159107 (NOVARTIS AG [CH]); | [Y]RU2318518 ; | International search | [AD]US2007027135 (BRUNCKO MILAN [US], et al); | [AP]WO2009073835 (ABBOTT LAB [US], et al); | by applicant | WO0057854 | WO0100175 | US2005208082 | US2005236236 | US2007027135 | WO2007040650 |